Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Trump’s messy handling of the Iran conflict has helped birth an axis that brings nuclear capability, serious money, and growing international clout together.